These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2857104)

  • 21. Therapeutic efficacy of a somatostatin analogue (SMS 201-995) in active acromegaly.
    Tolis G; Yotis A; del Pozo E; Pitoulis S
    J Neurosurg; 1986 Jul; 65(1):37-40. PubMed ID: 2872284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists.
    Howlett TA; Willis D; Walker G; Wass JA; Trainer PJ;
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):689-99. PubMed ID: 23574573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
    Karavitaki N; Botusan I; Radian S; Coculescu M; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years.
    Lamberts SW; Uitterlinden P; del Pozo E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):703-10. PubMed ID: 2888785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic profile in patients with acromegaly treated with somatostatin analogue.
    Valea A; Carsote M; Ghervan C; Georgescu C
    J Med Life; 2015; 8 Spec Issue(Spec Issue):82-6. PubMed ID: 26361517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.
    Plewe G; Schrezenmeir J; Nölken G; Krause U; Beyer J; Kasper H; del Pozo E
    Klin Wochenschr; 1986 Apr; 64(8):389-92. PubMed ID: 2871221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
    J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly.
    Chang JS; Tseng HM; Chang TC
    J Formos Med Assoc; 2016 Jun; 115(6):475-80. PubMed ID: 27117887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations.
    Spinas GA; Zapf J; Landolt AM; Stuckmann G; Froesch ER
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):249-56. PubMed ID: 2881419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis.
    Gurel MH; Han Y; Stevens AL; Furtado A; Cox D
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):22. PubMed ID: 28372573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
    Öberg K; Lamberts SW
    Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly.
    Tauber JP; Babin T; Tauber MT; Vigoni F; Bonafe A; Ducasse M; Harris AG; Bayard F
    J Clin Endocrinol Metab; 1989 May; 68(5):917-24. PubMed ID: 2565913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term pre-surgical treatment with somatostatin analogues, octreotide and lanreotide, in acromegaly.
    Waśko R; Ruchała M; Sawicka J; Kotwicka M; Liebert W; Sowiński J
    J Endocrinol Invest; 2000 Jan; 23(1):12-8. PubMed ID: 10698045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide.
    Page MD; Millward ME; Taylor A; Preece M; Hourihan M; Hall R; Scanlon MF
    Q J Med; 1990 Feb; 74(274):189-201. PubMed ID: 2111918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose tolerance during long term treatment with a somatostatin analogue.
    Verschoor L; Lamberts SW; Uitterlinden P; Del Pozo E
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1327-8. PubMed ID: 2878704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.
    Candrina R; Gussago A; Giustina G
    J Endocrinol Invest; 1988 Jan; 11(1):21-6. PubMed ID: 2896207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.